by Kerry Myers | Oct 19, 2023 | Case Study
CalCog’s established returns for redistribution procedure aids sponsor in keeping pivotal trial on time and in budget. A clinical-stage pharmaceutical company with a novel therapeutic for a common yet debilitating condition discovered that product distribution for its...
by Kerry Myers | Aug 10, 2023 | Case Study
A novel approach to wallet card design & manufacturing helps an innovator avoid costly Phase III study delays. A global biopharmaceutical company sponsored a Phase III, randomized, double-blind study to gain approval for extending its commercially available...
